Health News Releases

  • Today September 21
June 07, 10:00
IPS Appoints Jim Stephanou as New CEO
IPS, a leading provider of architecture, engineering, procurement, construction management, and validation services for the life sciences sector, announces the appointment of Jim Stephanou, as its new
basgenbio Inc.
June 07, 09:00
Basgenbio Presents at the BIO International Convention 2023
Basgenbio Inc., a clinico-genomic cohort data-based R&D company, announced that the company will presenting at the BIO International Convention 2023 (BIO USA), which will be held in Boston, MA, USA,
June 04, 10:20
AOP Health: Completed Study Strengthens Clinical Development Program for ropeginterferon alpha 2b (Besremi®) in polycythaemia vera
With the publication of the final results from the LOW-PV study in the New England Journal of Medicine Evidence conducted by Fondazione per la Ricerca dell'Ospedale di Bergamo (FROM) under the leaders
June 02, 11:55
Carbios Will Receive Grants Totaling €54 Million From French State via France 2030 and Grand-Est Region[1] to Finance Construction of World's First PET Biorecycling Plant and Accelerate R&D Activities
Regulatory News: Carbios (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies for reinventing the life cycle of plastics and textiles, annou
June 01, 14:55
JSR Life Sciences Announces Operational Consolidation of KBI Biopharma, Inc. and Selexis SA to Operate as one Organization, Providing Seamless Experience for Partners
JSR Life Sciences today announced that KBI Biopharma, Inc. (KBI) and Selexis SA are consolidating as one organization under the KBI Biopharma name to accelerate innovation and growth for its global bi
June 01, 14:20
Biocytogen Opens San Francisco Office to Accelerate Globalization
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) has announced the opening of a new office in San Francisco, California, USA. The new space will aim to accelerate the globali
June 01, 14:00
Kenvue to Participate in the Deutsche Bank dbAccess Global Consumer Conference on June 8, 2023
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced the company’s participation in Deutsche Bank’s dbAccess Global Consumer Conferenc
May 29, 15:07
Takeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
Takeda (TSE:4502/NYSE:TAK) and HUTCHMED (China) Limited (Nasdaq/AIM:HCM, HKEX:13) (HUTCHMED) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review of the New Dru
May 29, 14:36
Takeda to Present Oncology Portfolio and Pipeline Data at the 2023 ASCO Annual Meeting and EHA Congress
Takeda (TSE: 4502/NYSE:TAK) today announced that it will present data from its expanding oncology pipeline and established product portfolio at the 59th Annual Meeting of the American Society of Clini
May 26, 11:55
Merck Highlights Commitment to Improving Cancer Outcomes at ASCO 2023
Merck, a leading science and technology company, today announced that 43 abstracts covering several modalities and mechanisms will be presented at the 2023 American Society of Clinical Oncology (ASCO)
May 25, 11:30
TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion
TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the expansion of its mRNA manufacturing capab
May 24, 17:10
Burjeel Medical City Launches Advanced Gynecology Institute to Offer Complex Care Solutions for Women
Burjeel Medical City, the flagship facility of Burjeel Holdings, has launched an Advanced Gynecology Institute (AGI) designed to offer multidisciplinary healthcare solutions to women of all ages. The
May 24, 15:30
ReNAgade Therapeutics Launches with over $300 Million in Series A Financing To Unlock the Limitless Potential of RNA Medicine
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines to correct disease, today announced a $300 million Series A financing round led by MPM BioImpact and F2 Ventures.
Siemens Ltd. Seoul’s ‘The NANUM’ volunteer corps is serving Chicken Soup with Oriental Medicines to
May 19, 13:26
Siemens Korea conducts volunteer activities for local senior citizens in celebration of Family Month
A global powerhouse in electrical engineering and electronics, Siemens Korea (Siemens Ltd. Seoul·SLS) announced that the company served meals to the elderly in celebration of Family Month, on May 19.
May 18, 13:50
Alliance Pharma and Drug Development Solutions Are Now Resolian
Alliance Pharma, a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, and Drug Development Solutions, Ltd. (acquired in 2022),
May 17, 16:52
Next&Bio Signs MOU with Cancer Science Institute of Singapore for Organoid Collaboration
Next&Bio Inc. (Co-CEO: HyunSook Lee, Ji-Hun Yang), a company that has developed an organoid-based precision medicine drug discovery and development platform, has signed a memorandum of understanding (
May 17, 10:55
Parse Biosciences Expands Global Access to Israel
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Israel-based Ornat Biochemicals and Laboratory Equipment to extend
May 17, 09:40
UK’s Nurse Margaret Wins the Coveted Aster Guardians Global Nursing Award 2023
Margaret Helen Shepherd from UK has been announced as the winner of the Aster Guardians Global Nursing Award 2023 in a prestigious award ceremony held at Queen Elizabeth II Centre in London. The winne
May 16, 17:20
Carbios Recognized as a Flagship Start-up in French Green Innovation at the Choose France Summit
Regulatory News: Carbios (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, has been s
May 16, 15:50
AOP Health congratulates FROM on its great scientific work in the field of myeloproliferative neoplasms
Fondazione per la Ricerca dell'Ospedale di Bergamo (FROM) announced the publication of the latest results from the LOW-PV trial in the NEJM Evidence. The findings support a paradigm shift in the tr
May 15, 10:02
Nagasaki University Presented Results Of a Specified Clinical Trial On The Use of L. lactis strain Plasma For Patients With COVID-19
Nagasaki University presented the results of a specified clinical trial on patients with COVID-19 using Lactococcus. lactis strain Plasma[1](L.lactis Plasma, a postbiotic), researched and developed by
May 14, 10:15
AOP Health Presents New Findings Regarding Consistent Hematologic Response of Patients With polycythaemia vera
AOP Health announced new results on ropeginterferon alfa-2b (BESREMi®) from its clinical study CONTINUATION-PV in patients with polycythaemia vera (PV), a rare blood cancer. Professor Heinz Gisslinger
May 12, 14:45
Takeda Delivers Strong Revenue and Profit Growth in FY2022; Updated Capital Allocation Policy Reflects Deleveraging Progress and Confidence in Growth Outlook
Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for fiscal year 2022 (period ended March 31, 2023), delivering or exceeding management guidance, driven by the performance of its
May 12, 09:35
SINOVAC’s CoronaVac® Answers Hong Kong’s Need for Self-Pay COVID-19 Vaccines
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced it will provide its inactivated COVID-19 vaccine, CoronaVac®
May 11, 13:29
Oncocross Completes Phase 1 Global Clinical Trial of OC514, Treatment for Sarcopenia
Oncocross, a Seoul-based AI drug discovery and development biotech, announced the completion of phase 1 global clinical trial of OC514, a treatment targeting sarcopenia and other rare muscular disease
May 10, 17:22
Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight
Boehringer Ingelheim and Zealand Pharma A/S (Nasdaq: ZEAL) today announced that patients treated with BI 456906 achieved up to 14.9% weight loss after 46 weeks, using the planned maintenance dose. The
May 10, 15:40
Boehringer Ingelheim Begins Clinical Development of First-In-Class Treatment for Fibrotic Diseases
Boehringer Ingelheim announced today that it has launched clinical development of its first-in-class IL-11 inhibitor antibody BI 765423 with a Phase 1 study (NCT05658107) to assess the safety, tolerab
May 10, 14:50
Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor
Zion Pharma Limited, a Chinese biotechnology company focused on the development of brain-penetrable compounds, today announced that Roche has acquired the global rights to Zion’s lead program, ZN-A-10
May 10, 11:30
Kenvue Announces Closing of Initial Public Offering
Kenvue Inc. (NYSE: KVUE) (“Kenvue”) the world’s largest pure-play consumer health company by revenue, today announced the closing of its initial public offering (“IPO”) of 198,734,444 shares of its co
May 10, 10:15
Four Analyses of Data for REBYOTA™ (fecal microbiota, live - jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. difficile Infection, Presented at DDW 2023
Ferring Pharmaceuticals today announced three oral presentations and one poster presentation at Digestive Disease Week® (DDW 2023) for REBYOTA™ (fecal microbiota, live - jslm) a first-in-class single-
May 09, 16:55
Amicogen and Lysando: Novel Approach for the Treatment of Mastitis in Dairy Cows
Amicogen, a leading biotech company specializing in industrial enzyme production and drug development, has partnered with Lysando, an innovative biotech company with expertise in the development of an
May 09, 10:40
Cambridge University Hospitals Expands Virtual Care Program with Masimo W1™
Masimo (NASDAQ: MASI) today announced that Cambridge University Hospitals NHS Foundation Trust, U.K. is adopting the Masimo W1™ advanced health tracking watch for use in its telehealth and telemedicin
May 08, 09:05
Aquyre Biosciences Announces Appointment of F. Samuel Eberts III as CEO and Chairman of the Board of Directors & Founder Bertrand de Poly as Chief Strategy & Technology Officer
Aquyre Biosciences, Inc. today announced the appointment of F. Samuel Eberts III as Chief Executive Officer and Chairman of its Board of Directors. Founder Bertrand de Poly will assume the role of Chi
May 07, 14:45
Kenvue to Begin Trading on the New York Stock Exchange
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, will begin trading today on the New York Stock Exchange under the ticker symbol “KVUE” in connect
May 03, 14:00
SPEVIGO® granted Breakthrough Therapy Designation in the U.S. for the prevention of generalized pustular psoriasis flares
Boehringer Ingelheim announced today that spesolimab (marketed as SPEVIGO®) received Breakthrough Therapy Designation (BTD) as an investigational treatment for the prevention of flares in adolescents
April 27, 11:45
New Point-of-Care Diagnostics Video from Nordson EFD Explains How Precise Fluid Dispensing Improves Production Accuracy
Nordson EFD, a Nordson company (NASDAQ: NDSN) and leading precision fluid dispensing systems manufacturer, introduces a new animated video focused on point-of-care diagnostic dispensing applications w
April 25, 09:30
MDimune Wins Bronze at 2023 Edison Awards
MDimune Inc., a biotech company developing BioDrone™ platform technology, has won the Bronze Award at the 2023 Edison Awards. The company has won in the Health, Medical & Biotech category for its next
April 23, 10:13
Dental Monitoring files a new claim against Get-Grin Inc. for patent infringement relating to its DM ScanBox device
Dental Monitoring has filed a lawsuit against Get-Grin Inc. (“Get Grin”) with the United States District Court for the District of Delaware alleging infringement of two of its patents (U.S. Patent Nos
April 20, 15:40
Aleph Farms Launches New Product Brand Aleph Cuts
Aleph Farms, a food technology company designing new ways to grow quality animal products, today announced the launch of its first product brand, Aleph Cuts. Under the Aleph Cuts brand, the company wi
April 19, 14:57
Augmented Reality: Patient Experience Trumps Misconceptions Around Injectables
New global research,[2] sponsored by Galderma and released today by leading filler brand Restylane®, has revealed the prevalent societal misconceptions and stereotypes facing the aesthetics industry.
April 19, 14:30
PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced that three new state-of-the-art automated sterile fill-finish machines at its Sa
April 19, 11:10
Armis Announces Significant Business Momentum in Healthcare
HIMSS - Armis, the leading asset visibility and security company, today announced significant business momentum in the healthcare sector driven by healthcare and life sciences companies choosing the A
Ferring and BioInnovation Institute enter new strategic collaboration to accelerate innovation in wo
April 18, 17:07
Ferring and BioInnovation Institute enter new strategic collaboration to accelerate innovation in women’s health
Ferring Pharmaceuticals and BioInnovation announce a new strategic collaboration to accelerate innovation in women’s health. BioInnovation Institute Foundation (BII) and Ferring Pharmaceuticals A/S
April 18, 10:10
KBI Biopharma and Selexis SA Appoint J.D. Mowery as CEO
KBI Biopharma, Inc. (KBI) and Selexis SA, both JSR Life Sciences companies, today announced the appointment of J.D. Mowery as Chief Executive Officer (CEO). Widely respected as an innovative biotech l
April 16, 15:18
AristaCare Health Services: The Future of Post-Acute Rehab and Long-Term Care
For over 20 years, AristaCare Health Services has been providing exceptional post-acute rehabilitation, memory care, and long-term care services to patients and residents in New Jersey and Pennsylvani
April 14, 11:00
Yong Chul Shin, Ph.D., is Chief Scientific Officer of Lysando AG
Lysando AG - market leader in the field of antimicrobial proteins - is pleased to announce that Dr. Yong Chul Shin has joined the team as CSO in April. Dr. Shin will be responsible for leading the com
April 13, 13:55
Berry Consultants Releases FACTS 7 Clinical Trial Simulator
Berry Consultants, LLC announced today that FACTS 7 was released to existing users and is now available to all new clients. FACTS (Fixed and Adaptive Clinical Trial Simulator) is the most powerful, fl
April 12, 16:30
Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled Phase III Evobrutinib Studies Continue
Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the initiation of new patients on evobrutinib and pat
April 06, 11:55
Panda Biotech Announces Landmark Equity Partnership With Southern Ute Growth Fund Aka-Ag, LLC
Panda Biotech announces a landmark equity partnership deal between the Panda High Plains Hemp Gin™ (PHPHG) project and the Southern Ute Indian Tribe Growth Fund (Growth Fund). The Growth Fund is owned
April 06, 09:35
Aleph Farms Joins the United Nations Global Compact
Aleph Farms, the first company to grow cultivated steaks directly from non-modified cow cells, today announced that it has joined the United Nations Global Compact, a voluntary leadership platform for
25 per page50 per page75 per page100 per page